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American Academy of Pediatrics (AAP) recommends investigating for urinary tract infection (UTI) in neonates with conjugated hyperbilirubinemia,[1] but 
UTI may be associated with unconjugated hyperbilirubinemia 
also.[2,3] There are studies regarding the relationship of 
idiopathic hyperbilirubinemia and bacterial infections such 
as UTI.[2] Direct hyperbilirubinemia associated with UTI may 
be due to cholestasis as a result of microcirculatory disorders 
in the liver, direct bacterial products, or endotoxin-induced 
mediators[4] while indirect hyperbilirubinemia may be due 
to hemolysis caused by Escherichia coli and other Gram-
negative microorganisms.[5,6] Lee et al.[3] observed that infants 
with UTI may present with unconjugated hyperbilirubinemia 
in the early stage but after 6 weeks, it is always conjugated 
hyperbilirubinemia. Therefore, the present study was 
conducted to evaluate the frequency of UTI in initial 4 weeks 
of life in pathological unconjugated hyperbilirubinemia and 
to study the effect of the treatment of UTI on the course of 
hyperbilirubinemia in these neonates.
MATERIALS AND METHODS
The prospective cohort study was conducted in referral neonatal unit 
of a teaching hospital over 12-month period starting from March 
2014 to February 2015. The study was approved by the institutional 
ethical committee in November 2013. Informed written consent was 
obtained from parents of all subjects before enrollment in the study.
Neonates (gestational age ≥35 weeks and <42 weeks) with 
unconjugated hyperbilirubinemia in pathological range were 
included in the study.[1] Neonates treated with exchange transfusion 
before admission were excluded from the study. Based on the 
past 12-month admission rate in the referral neonatal unit with 
requisite inclusion and exclusion criteria, a convenient sample 
size of 100 consecutive neonates was included in the study.
Outcome Variable
Primary: The presence of UTI confirmed by a positive urine 
culture with more than 10,000 CFUs/mL of a single pathogen.[7] 
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Secondary: Positive leukocyte esterase (LE) and nitrite reactions, 
significant pyuria (defined as more than 10 pus cells per high 
power field of an uncentrifuged urine sample), and rate of fall of 
bilirubin levels.
Baseline characteristics included sex, age, and weight at 
enrollment, and gestational age was collected in a predesigned 
pro forma. History was elicited from mother or from a reliable 
informant and recorded. Antenatal history included booking status 
of pregnancy, gestational diabetes, pregnancy-induced hypertension, 
risk factors for early-onset sepsis, oxytocin usage, duration of 
labor, and drug intake. Birth history regarding birth order, multiple 
pregnancy, mode, and place of delivery, asphyxia, and resuscitation 
required were recorded. Sibling history included jaundice in the 
previous sibling, neonatal death due to jaundice, and unexplained 
death. Feeding history included initiation, duration, and frequency 
of breastfeeding. Details of top feeds such as type, frequency, and 
dilution were also asked. History of previous nursery admissions, 
intravenous fluid therapy, duration, dosage and name of antibiotics 
received, and details of urinary catheterization were also included. 
Age at onset of jaundice, presence of acute bilirubin encephalopathy, 
and treatment of hyperbilirubinemia including type and duration of 
phototherapy and history of neonatal UTI such as fever, refusal to 
feed, vomiting, and blood in urine were recorded.
Clinical assessment was done at enrollment and the heart rate, 
respiratory rate, temperature, pallor, icterus, and its extent on 
the body were recorded. Clinical features of the acute bilirubin 
encephalopathy, namely mental state, muscle tone, and cry 
were observed daily and scored as per clinical bilirubin-induced 
neurologic dysfunction score.[8] Total and direct serum bilirubin 
was measured by direct spectrophotometry method.[9] Bilirubin 
measurement was repeated as per clinical condition and unit 
protocol until jaundice returned to physiological levels.
Urine collection and testing were done at enrollment by 
bladder catheterization under aseptic precautions, and catheter 
was removed immediately after urine collection. In neonates who 
were started on antibiotics, the urine sample was obtained before 
the first dose of antibiotic. Urine sample was divided into three 
parts and processed as detailed: One part was used for urine culture 
(semi-quantitative method with calibrated loop using MacConkey 
agar medium) within 4 h of collection or refrigerated at 4°C in case 
of delay, the second part was analyzed using Multistix 10 (Bayer, 
Germany) dipsticks for LE and nitrite tests,[10] and the third part 
was analyzed by microscope for the presence of pus cells.
Treatment protocols included the following: Total serum 
bilirubin (TSB) levels that require intervention (phototherapy 
or exchange transfusion) were considered as unconjugated 
pathological hyperbilirubinemia or pathological jaundice as per 
the AAP guidelines,[1] and neonates with positive urine culture 
growth or UTI were treated with antibiotics.[11,12]
Statistical Analysis
Data were entered into MS Excel programme and statistical 
analysis was done using Statistical Package for the Social 
Sciences (SPSS 16.0). Fischer’s exact test or the Chi-square test 
was applied for comparison of qualitative variables between two 
groups. For comparison of quantitative variables, Student’s t-test 
or Mann–Whitney U-test was applied based on the normality of 
the data. Normality of data was determined using Shapiro–Wilk 
test. p<0.05 was statistically significant. An intention to treat 
method of analysis was used.
RESULTS
During the 12-month study period, 1281 babies were admitted to 
the neonatal unit. 100 consecutive neonates satisfying inclusion 
criteria were enrolled in the study. Seven neonates had a positive 
urine culture growth fulfilling the primary outcome criteria (UTI 
group) while rest of the 93 babies without any bacterial growth in 
their urine constituted the non-UTI group (Table 1). Majority of 
the babies (80 of 93 babies in the non-UTI group and all the seven 
babies in the UTI group) were enrolled between 2 and 7 days of 
life (Fig. 1). Of 93 babies in the non-UTI group, 20 babies were 
preterm, two babies were very low birth weight (VLBW), and 
63 babies were low birth weight (LBW) while in the UTI group, 
only one baby was preterm and four babies were LBW. All the 
100 study subjects were singleton births. In the non-UTI group, 
three neonates died during the study period and four neonates left 
against medical advice, while in the UTI group one neonate was 
taken against medical advice (study compliance more than 85%).
The most common symptom among study subjects was the 
refusal of feeds (30.1% in the non-UTI group and 28.6% in the 
UTI group) followed by lethargy (18.2% in the non-UTI group 
and 28.6% in the UTI group). Fever was present in only one of 
the seven neonates in the UTI group (14.3%) (Table 2). In the 
non-UTI group, 21 neonates had acute bilirubin encephalopathy 
(ABE) at enrollment and four developed bilirubin encephalopathy 
during the hospital stay.
Total and direct serum bilirubin concentration was estimated 
at enrollment in all subjects. Fig. 1 depicts median TSB level in 
both non-UTI and UTI groups at the different age of enrollment. 
The median (range) TSB at enrollment (TSB-E) in the non-
UTI group was 20.70 (11–53) mg/dL and in the UTI group, it 
was 23.20 (17–26) mg/dL (p=0.665). The median (range) peak 
bilirubin value reached during the hospital stay in the non-UTI 
group was 21.60 (12–53) mg/dL, and in the UTI group, it was 
23.20 (17–26) mg/dL (Table 3).
17 subjects in the study group had evidence of hemolysis in 
the peripheral blood smear out of whom 11 neonates in the non-
UTI group and none in the UTI group had a positive Coombs 
test. Five neonates in the non-UTI group and one baby in the UTI 
group had non-isoimmune cause for hemolysis.
Urine dipstick analysis using Multistix 10 (Bayer, Germany) 
revealed positive LE reaction in six of the seven neonates (85.7%) 
with positive urine culture growth while none of the neonates 
in the non-UTI group had a positive reaction (Table 4). Five 
(71.4%) neonates had a positive nitrite reaction in the UTI group. 
Microscopic analysis of urine revealed pyuria in four of the seven 
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neonates (57.1%) in the UTI group. Urine culture revealed the 
growth of E. coli in six neonates and Pseudomonas species in one 
neonate.
19 neonates had received intravenous antibiotics and had a 
negative urine culture at enrollment. 18 neonates received two 
antibiotics each and mean (SD) antibiotic duration per baby was 
2.15 (0.3) days. None of the neonates in the UTI group were 
catheterized elsewhere before arrival to the hospital and had not 
received antibiotic before enrollment in the study.
All the study subjects were started on phototherapy at 
enrollment according to AAP guidelines.[1] In addition, exchange 
transfusion for hyperbilirubinemia was done in 23 neonates 
in the non-UTI group. The median duration of phototherapy 
in the remaining 70 neonates in the non-UTI group and seven 
neonates in the UTI group was comparable (p=0.943) (Table 5) 
with a comparable median rate of fall of bilirubin in the two 
groups (p=0.172). Further, on subgroup analysis of these babies 
without exchange transfusion and without evidence of hemolysis 
in the peripheral blood smear, the median (range) duration of 
phototherapy in 64 babies in the non-UTI group was 38 (15–117) 
h and in six babies in the UTI group was 38 (21–100) h, with a 
median (range) rate of fall of bilirubin of 0.16 (0.03–0.50) and 
0.22 (0.05–0.34) mg/dL/h, respectively.
Antibiotics were started after dipstick and microscopic 
analysis and urine culture. Intravenous antibiotics were given 
for 10–14 days. A second sample of urine for culture sent after 
completion of a course of sensitive antibiotics was sterile in all 
the treated neonates. Subsequently, neonates were started on oral 
cephalexin prophylaxis until structural anomalies of the urinary 
tract were ruled out. Ultrasound scanning of the kidney urinary 
bladder region was normal in all neonates except one in whom 
there was thickening of the urinary bladder which normalized 
on follow-up scan after 1 month. A voiding micturating 
Table 1: Baseline characteristics of study subjects
Characteristics Non‑UTI group (n=93) UTI group (n=7)
Age at enrollment (hours) mean (SD) 102.3 (60) 79.4 (17)
Sex female n (%) 24 (25.8) 1 (14.3)
Gestational age (weeks) mean (SD) 37.8 (1.6) 38.7 (1.9)
Enrollment weight (grams) Mean (SD) 2296 (453) 2565 (411)
Primi mother n (%) 37 (39.8) 5 (71.4)
Booked pregnancy n (%) 71 (76.3) 7 (100)
Gestational diabetes mellitus, Pregnancy-induced hypertension n (%) 7 (7.6) 0
Prolonged leaking Per vaginum n (%) 11 (11.8) 2 (28.5)
Induction of labor with oxytocin n (%) 11 (11.8) 2 (28.5)
Neonatal jaundice in sibling n (%) 11 (11.8) 0
Home delivery n (%) 28 (30.1) 1 (14.3)
Vaginal delivery n (%) 84 (90.3) 5 (71.4)
Resuscitation at birth n (%) 12 (12.9) 0
Exclusive breastfeeding n (%) 46 (49) 6 (85.7)
Study compliance n (%) 86 (92.5) 6 (85.7)
UTI: Urinary tract infection, SD: Standard deviation
Table 2: Clinical features of study subjects
Clinical features Non‑UTI group (n=93) (%) UTI group (n=7) (%)
Refusal of feeds 28 (30.1) 2 (28.6)
Lethargy 17 (18.2) 2 (28.6)
Fever 3 (3.2) 1 (14.3)
Arching of neck and trunk on stimulation 4 (4.3) 0
High pitched cry when aroused 3 (3.2) 1 (14.3)
Shrill cry, difficult to console 2 (2.1) 0
Apnea 1 (1.1) 0
Asymptomatic 62 (66) 5 (71.4)
UTI: Urinary tract infection
Figure 1: Severity of jaundice in study subjects at enrollment
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cysto-urethrogram done in all the seven neonates with a positive 
urine growth was normal.
DISCUSSION
The incidence of the UTI in general population in the neonatal age 
group is 0.1–1%.[13] In the present study, the incidence of the UTI 
in neonates with pathological unconjugated hyperbilirubinemia 
was 7% (seven out of 100 babies). In a study by Garcia et al. 
in 160 asymptomatic jaundiced infants younger than 8 weeks, 
UTI was found in 7.5% of cases out of whom two cases had 
direct hyperbilirubinemia.[14] In another study by Bilgen et al.,[15] 
the incidence of UTI in clinically well, <2-week-old jaundiced 
infants with a TSB level above 15 mg/dl were 7.8% (8 out of 
102 neonates). However, in a study by Mutlu et al.,[16] neonates 
aged 4–14 days of life with jaundice above phototherapy limits 
set by AAP guidelines, UTI was diagnosed in 19 of the enrolled 
104 neonates (18%). This higher incidence of UTI might be due 
to the exclusion of neonates in whom an apparent cause for the 
jaundice was present (blood group incompatibility, hemolysis in 
peripheral smear, or positive direct Coombs test) and thus there 
was a higher possibility of other causes such as UTI for jaundice 
in the included neonates. Further, in the study by Nejad et al., 
the incidence of UTI in neonates with clinical icterus was 18% 
(16 out of 90 neonates) and in this study also neonates with an 
apparent cause for jaundice was not included in the study.[17] In the 
present study, on subgroup analysis of babies without evidence 
of hemolysis in the peripheral blood smear, six out of 83 babies 
(7%) had associated UTI. Further, 19 out of 100 study subjects 
had received antibiotic therapy before enrollment and had a 
negative urine culture. This could also be considered as a reason 
for the relatively low incidence of UTI in the present study when 
compared with those of Mutlu et al. and Nejad et al.
Antibiotic treatment of UTI was started in all the seven 
neonates with a positive urine culture. All the study subjects 
were started on phototherapy at enrollment. None of the seven 
neonates in the UTI group developed ABE during the study 
period and did not require exchange transfusion for treatment 
of hyperbilirubinemia while in the non-UTI group 25 neonates 
developed ABE and 23 out of 93 (24.7%) neonates required 
exchange transfusion (p=0.1974). The median duration of 
phototherapy in the non-UTI group who did not require exchange 
Table 4: Result of urine analysis and culture
Case No. LE reaction Nitrite reaction Pyuria Organism (CFU/mL) Sensitive to antibiotics
6 Positive Positive Present E. coli (105) NFT, Cipro
9 Positive Positive Present E. coli (106) Ceph, Amox
17 Positive Positive Absent E. coli (105) Genta, NFT
18 Positive Negative Present E. coli (105) Genta, Cipro
32 Negative Negative Absent Pseudomonas species (106) Cipro, Ceft, Amika
81 Positive Positive Present E. coli (106) Cipro, Genta
87 Positive Positive Absent E. coli (106) Ceftr, Ceph
Amika: Amikacin, Amox: Amoxicillin, Ceftr: Ceftriaxone, Ceft: Ceftazidime, Ceph: Cephalexin, Cipro: Ciprofloxacin, Genta: Gentamycin, NFT: Nitrofurantoin, 
LE reaction: Leukocyte esterase reaction, CFU: Colony‑forming unit, E. coli: Escherichia coli
Table 5: Effect of treatment of UTI on hyperbilirubinemia
Parameters Non‑UTI group without ET (n=70) UTI group (n=7)
TSB-E (mg/dL) median (range) 19.40 (11–29) 23.20 (17–26)
TSB-P (mg/dL) median (range) 12.75 (6.2–20.9) 11.40 (7.6–18.2)
Duration of PT (hours) median (range) 39 (15–117) 36 (21–100)
Bilirubin fall (mg/dL/h) median (range)* 0.17 (0.01–0.5) 0.27 (0.05–0.42)
TSB‑E: Total serum bilirubin at enrollment, TSB‑P: Total serum bilirubin at stop of phototherapy, PT: Phototherapy, ET: Exchange transfusion, *p=0.1720, UTI: Urinary tract 
infection
Table 3: Biochemical profile of jaundice in study subjects
Parameter Range Non‑UTI group (n=93) (%) UTI group (n=7) (%)
TSB at enrollment (mg/dL) 0–11 0 0
11.1–15 7 (7.5) 0
15.1–25 63 (67.7) 5 (71.4)
More than 25 23 (24.7) 2 (28.6)
Maximum TSB (mg/dL) 0–11 0 0
11.1–15 6 (6.5) 0
15.1–25 61 (65.6) 5 (71.4)
More than 25 26 (28) 2 (28.6)
Development of conjugated bilirubinemia 3 (3.2) 0
UTI: Urinary tract infection, TSB: Total serum bilirubin
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transfusion was comparable to the neonates in the UTI group 
(p=0.943), again with a comparable rate of fall of bilirubin in the 
two groups (p=0.172). However, in the study by Mutlu et al.,[16] 
the duration of phototherapy was longer in those with UTI (42.9 
h) than those without UTI (32.6 h).
There are some limitations in the present study. The study was 
done in the referral neonatal unit involving outborn neonates in 
whom onset and progression of jaundice and clinical features of 
UTI could not be followed from birth; 19 neonates had received 
antibiotics before urine culture, and this could have affected 
the culture positivity rate in these study subjects. Therefore, 
to evaluate cause and effect relationship between UTI and 
unconjugated hyperbilirubinemia, a study in an inborn nursery 
setting is suggested for future research.
CONCLUSION
UTI in the newborn period can present with indirect 
hyperbilirubinemia. Evaluation for neonatal UTI as a cause of 
non-hemolytic pathological unconjugated hyperbilirubinemia 
with urine multi dipsticks and microscopy, and urine culture 
should be recommended, even in the 1st week of life as in the 
present study, the incidence of UTI in jaundiced neonates was 7% 
(higher than normal population) and the mean age at enrollment 
of neonates with UTI was 79.4 h.
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